The global continuous glucose monitoring systems market size was valued at USD 5.24 billion in 2025 and is projected to grow from USD 6.35 billion in 2026 to USD 29.57 billion by 2034, registering a CAGR of 21.2% during the forecast period from 2026 to 2034. North America dominated the continuous glucose monitoring systems market with a market share of 42.35% in 2025.
Continuous glucose monitoring (CGM) systems are medical devices designed to continuously measure and track glucose levels in the interstitial fluid throughout the day and night. These systems typically consist of a wearable sensor, a transmitter, and a receiver or compatible smart device that provides real-time glucose readings, trends, and alerts. Continuous glucose monitoring systems enable individuals with diabetes and healthcare providers to monitor glucose fluctuations more effectively, support timely treatment decisions, improve glycemic control, and reduce the risk of hypoglycemia and hyperglycemia. They are widely used in diabetes management to enhance patient outcomes, facilitate personalized care, and improve overall quality of life.
Download a Free Sample To learn more about this report,
Growing Adoption of AI-Enabled and Connected Diabetes Management Solutions
The continuous glucose monitoring (CGM) systems market is witnessing a strong trend toward AI-enabled, connected, and personalized diabetes management solutions. Manufacturers are increasingly integrating continuous glucose monitoring systems with insulin pumps, mobile health applications, cloud platforms, and artificial intelligence to provide real-time glucose insights, predictive alerts, and automated insulin delivery. The growing adoption of wearable medical devices, rising preference for minimally invasive glucose monitoring technologies, and increasing demand for home-based diabetes management are further accelerating market growth. Additionally, continuous advancements in sensor accuracy, longer sensor wear time, and smartphone connectivity are improving patient convenience, treatment adherence, and overall diabetes management outcomes across all age groups.
Rising Prevalence of Diabetes and Growing Demand for Continuous Glucose Monitoring
The increasing prevalence of diabetes worldwide is a major factor driving the growth of the continuous glucose monitoring (CGM) systems market. Rising urbanization, sedentary lifestyles, unhealthy dietary habits, and the growing incidence of obesity have significantly increased the number of individuals diagnosed with type 1 and type 2 diabetes. This has created strong demand for continuous glucose monitoring systems that provide real-time glucose tracking, improve glycemic control, and reduce the risk of diabetes-related complications. In addition, favorable reimbursement policies, increasing awareness of advanced diabetes management technologies, and continuous product innovations are encouraging the adoption of CGM systems across hospitals, clinics, and home healthcare settings.
Limited Diagnosis and Access to Advanced Diabetes Care in Developing Countries
Limited diagnosis rates and inadequate access to advanced diabetes care continue to restrain the growth of the continuous glucose monitoring systems market. Many developing countries face challenges such as low awareness of diabetes, delayed diagnosis, insufficient healthcare infrastructure, and limited availability of specialized diabetes management services. Additionally, the high cost of CGM systems, lack of reimbursement coverage, and affordability concerns restrict adoption among patients, particularly in low- and middle-income economies. These factors continue to limit the widespread utilization of continuous glucose monitoring technologies despite the increasing burden of diabetes.
Expanding Adoption of Advanced and Non-Invasive CGM Technologies
The increasing adoption of advanced and non-invasive continuous glucose monitoring technologies presents significant opportunities for the market. Manufacturers are focusing on developing highly accurate, minimally invasive, and wearable CGM systems integrated with artificial intelligence, smartphone connectivity, and cloud-based data analytics to improve patient convenience and treatment outcomes. The growing preference for real-time glucose monitoring, personalized diabetes management, and automated insulin delivery systems is encouraging healthcare providers and patients to transition from conventional blood glucose monitoring devices to advanced CGM solutions. Continuous innovation in sensor technology and digital health platforms is expected to further expand market opportunities.
High Cost of Continuous Glucose Monitoring Systems
The high cost of continuous glucose monitoring systems remains a major challenge for the market, particularly in emerging economies. Advanced CGM devices involve recurring expenses related to sensors, transmitters, and software subscriptions, making long-term usage financially challenging for many patients. Limited reimbursement coverage and disparities in healthcare funding further reduce affordability, especially in low-income regions. Additionally, healthcare providers must address cost concerns while ensuring broader access to advanced diabetes management technologies, which continues to be a key challenge for market expansion.
Request Customizationto receive a tailored report.
Sensors Segment Dominated the Market with 52.82% Share in 2025
The sensors segment dominated the continuous glucose monitoring systems market with the largest revenue share of 52.82% in 2025. The segment's dominance is attributed to the critical role sensors play in continuously measuring glucose levels and delivering accurate, real-time data for effective diabetes management. Continuous advancements in sensor technology, including improved accuracy, extended wear duration, enhanced comfort, and reduced calibration requirements, are further driving the adoption of CGM systems across both clinical and homecare settings.
The market also comprises transmitters and receivers, which play an essential role in transmitting and displaying glucose data. Continuous improvements in wireless connectivity, smartphone integration, cloud-based monitoring, and data-sharing capabilities are expected to support steady demand for these components throughout the forecast period.
Child Population (≤14 Years) Segment is Expected to Register the Fastest CAGR of 11.58% During the Forecast Period
The child population (≤14 years) segment is projected to register the fastest CAGR of 11.58% during the forecast period. The increasing prevalence of type 1 diabetes among children, growing awareness of early diabetes management, and rising adoption of wearable glucose monitoring technologies are driving segment growth. Continuous glucose monitoring systems enable caregivers and healthcare professionals to monitor glucose levels in real time, helping improve treatment outcomes while reducing the risk of severe hypoglycemic and hyperglycemic events.
The market also serves the adult population (>14 years), which continues to account for a significant share due to the high prevalence of type 2 diabetes and the growing adoption of advanced diabetes management solutions. Increasing healthcare awareness, favorable reimbursement policies, and continuous technological innovations are expected to sustain demand across the adult patient population.
Homecare Settings Segment Dominated the Market with 63.53% Share in 2025
The homecare settings segment dominated the continuous glucose monitoring systems market with the largest revenue share of 63.53% in 2025. The segment's leadership is driven by the growing preference for home-based diabetes management, increasing adoption of wearable CGM devices, and advancements in remote patient monitoring technologies. Patients increasingly prefer homecare settings due to greater convenience, continuous glucose monitoring, reduced hospital visits, and improved disease management through smartphone-connected and cloud-enabled CGM systems.
The market also includes hospitals, which continue to witness steady demand for continuous glucose monitoring systems, particularly for managing critically ill patients and individuals requiring intensive diabetes care. Increasing integration of CGM technologies into hospital workflows and expanding use of digital health solutions are expected to support continued growth in this segment.
Speak to an Analystto discuss market opportunities.
North America dominated the continuous glucose monitoring systems market with the largest revenue share of 42.35% in 2025 and was valued at USD 2.22 billion. The regional market is driven by the high prevalence of diabetes, widespread adoption of advanced diabetes management technologies, and favorable reimbursement policies. Strong healthcare infrastructure, increasing awareness of continuous glucose monitoring, and the presence of leading medical device manufacturers continue to accelerate the adoption of CGM systems across hospitals, clinics, and homecare settings.
The United States continuous glucose monitoring systems market was valued at USD 1.76 billion in 2025. Market growth is driven by the rising prevalence of type 1 and type 2 diabetes, increasing adoption of wearable medical devices, and continuous technological advancements in connected CGM systems. Favorable insurance coverage and growing demand for personalized diabetes management solutions further support market expansion.
The Canada continuous glucose monitoring systems market was valued at USD 0.46 billion in 2025. The market is supported by increasing healthcare expenditure, growing awareness of diabetes management, and expanding reimbursement programs for continuous glucose monitoring devices. Rising adoption of home-based healthcare solutions is further contributing to market growth.
Europe accounted for 27.18% of the global continuous glucose monitoring systems market in 2025 and was valued at USD 1.42 billion. The regional market is driven by increasing diabetes prevalence, strong government support for chronic disease management, and growing adoption of advanced wearable medical devices. Rising investments in digital healthcare and favorable reimbursement policies continue to promote the widespread use of continuous glucose monitoring systems across the region.
The Germany continuous glucose monitoring systems market was valued at USD 0.43 billion in 2025. Market growth is supported by the country's advanced healthcare infrastructure, increasing adoption of digital diabetes management technologies, and growing demand for wearable glucose monitoring devices. Continuous innovation in diabetes care is further strengthening market expansion.
The United Kingdom continuous glucose monitoring systems market was valued at USD 0.34 billion in 2025. Increasing government initiatives to improve diabetes care, expanding access to CGM technologies through public healthcare programs, and growing awareness of continuous glucose monitoring are driving market growth.
Asia Pacific held 21.46% of the global continuous glucose monitoring systems market in 2025 and was valued at USD 1.12 billion. The region is expected to witness the fastest growth during the forecast period due to the rapidly increasing diabetic population, improving healthcare infrastructure, and growing awareness of advanced diabetes management technologies. Rising healthcare investments and expanding access to wearable medical devices are further accelerating market growth across emerging economies.
The China continuous glucose monitoring systems market was valued at USD 0.47 billion in 2025. The market is driven by the country's large diabetic population, increasing healthcare expenditure, and growing adoption of digital health technologies. Government initiatives promoting chronic disease management and continuous innovation in medical devices are further supporting market expansion.
The Japan continuous glucose monitoring systems market was valued at USD 0.26 billion in 2025. Market growth is supported by the country's aging population, increasing prevalence of diabetes, and strong adoption of advanced healthcare technologies. Rising demand for home-based diabetes management solutions continues to strengthen the market.
Latin America accounted for 5.32% of the global continuous glucose monitoring systems market in 2025 and was valued at USD 0.28 billion. The regional market is driven by increasing diabetes awareness, improving healthcare access, and rising investments in medical technology. Growing adoption of wearable glucose monitoring devices and expanding healthcare infrastructure are expected to support steady market growth.
The Brazil continuous glucose monitoring systems market was valued at USD 0.14 billion in 2025. Rising prevalence of diabetes, increasing government initiatives to improve diabetes care, and expanding access to advanced glucose monitoring technologies are driving market growth. Growing investments in healthcare infrastructure are further supporting market expansion.
The Middle East and Africa accounted for 3.69% of the global continuous glucose monitoring systems market in 2025 and were valued at USD 0.19 billion. The regional market is driven by the increasing burden of diabetes, improving healthcare infrastructure, and growing investments in chronic disease management. Rising awareness of continuous glucose monitoring technologies and expanding access to modern medical devices are expected to support market growth during the forecast period.
The UAE continuous glucose monitoring systems market was valued at USD 0.06 billion in 2025. Market growth is supported by increasing healthcare expenditure, rising adoption of digital health technologies, and strong government initiatives to improve diabetes management. Growing demand for home-based monitoring solutions is further driving the adoption of continuous glucose monitoring systems.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Analyst
Jay Mehta is a Research Analyst with over 4 years of experience in the Medical Devices industry. His expertise spans market sizing, technology assessment, and competitive analysis. Jay’s research supports manufacturers, investors, and healthcare providers in understanding device innovations, regulatory landscapes, and emerging market opportunities worldwide.
We are featured on:
sales@straitsresearch.com